News Breaks |
|
|
| November 16, 2012 |
| 13:50 EDT |  | MDT | Medtronic volatility flat into Q2 results and outlook
Medtronic December put option implied volatility is at 24, January and February is at 23; compared to its 26-week average of 22 according to Track Data, suggesting non-directional price movement into the release of Q2 results on November 20. |
|
|
News For MDT From The Last 14 Days Check below for free stories on MDT the last two weeks. |
|
|
| May 16, 2013 |
| 13:32 EDT | | MDT | Medtronic volatility flat into Q4 and outlook
 Subscribe for More Information |
|
| 10:03 EDT |  | MDT | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 06:32 EDT | | MDT | Medtronic downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information |
|
| May 10, 2013 |
| 15:49 EDT |  | MDT | Medtronic defibrillators demonstrate success of shock avoidance
Subscribe for More Information |
|
| May 8, 2013 |
| 07:38 EDT |  | MDT | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| May 6, 2013 |
| 09:19 EDT | | MDT | Medtronic receives FDA approval for newest cardiac devices
Medtronic announced FDA approval and U.S. launch of its newest cardiac devices: the Viva portfolio of cardiac resynchronization therapy with defibrillation, or CRT-D, devices, and the Evera portfolio of implantable cardioverter-defibrillators. |
|
|
|
|
|
